How do you create loyalty through elevated experience?

IA Collaborative supported Audi in developing the digital ownership platform, myAudi, plus the Audi Academy training platform, brand ambassador Welcome Kit, and intelligent sales enablement tools. In a world where transportation expectations are continuously evolving, this multi-pronged approach empowered Audi dealers with the tools to create meaningful moments for their customers and elevate the total customer experience.

1 / Driving Impact by Elevating the Moments That Matter

By taking an in-depth look at key customer moments in dealerships across the country, IA identified digital, brand, and spatial opportunities to support Audi Brand Ambassadors. Multiple rounds of research uncovered how sales strategies varied from one ambassador to the next, and the team realized it was important to create a system that flexed to individual needs while still emphasizing Audi’s unified brand across tools. The team developed an integrated communications roadmap that would not only empower the sales team to close more deals, but also help the business at large reduce salesperson attrition, reduce costs associated with training, and help leadership better understand their dealers’ sales journey.

2 / Digital Ownership for a Seamless Experience

Audi’s technology-forward and sophisticated brand identity informed a sleek, customer-centric visual system that would translate to the digital ownership interface for the myAudi program. IA also developed physical installations, branded training materials, and a digital sales-enablement platform. This system of assets was developed to create a connected, personalized experience from the dealer training room to the sales floor and designed to create trust between the salesperson and consumer.

3 / Building Trust & Engagement Through Dealer Support

In the face of an industry being heavily disrupted, the team focused not on changing the product or the company’s brand, but instead, invested in understanding Audi’s dealers, their processes, and how best to enable them to do their best work. In doing so, the team created a system of tools that empowered dealers to take a personalized approach to sales while staying true to Audi’s brand. This, in turn, allowed for an individualized but brand-consistent model of iteration that shaped the consumer digital ownership platform, myAudi.

Work

How do you create digital therapies and prescribable apps to improve health outcomes?

Digital Therapies

With most patients having limited quality time with their doctors, how can digital solutions empower patients to manage their own care, and serve as a "proxy" for the doctor in between visits? At IA Collaborative, we've been working with the world's largest pharmaceutical companies to conceive, design and launch new-to-the-world digital therapies and prescribable apps. The solutions are intuitive, seamless, and connected across the entire healthcare ecosystem from patients to payers, to providers and caregivers. While the digital therapy space is a clear growth market within healthcare, creating and launching solutions requires new collaboration models that balance human-centered design and product strategy, agile development, and a careful navigation of regulatory requirements.

1 / Patient Outcomes: Strengthening the Impact a Drug Can Have

Digtal therapies that capture patient data and provide hyper-personalized support enable pharmaceutical companies to connect directly with patients and improve their outcomes. Digital therapies enable Pharma organizations to differentate themselves while driving consumer preference and loyalty. IA Collaborative works with these organizations to define their ownable opportunity wtihin this $1 Trillion potential market.

2 / Uncovering User Needs & Market Opportunity

From diabetes to dialysis, we’re uncovering unique opportunities for digital solutions to play a role in improving patient care and achieving better health outcomes. Digital solutions provide benefits that doctor’s visits and drugs alone cannot, including support and asynchronous communication between check-ups; objective data vs. self-reported adherence and behavioral data; and enhanced “real-time” collaboration opportunties between doctors, patients, and caregivers.

3 / From Insight to Implementation

Launching connected digital solutions within large Pharma organizations requires the right organizational infrastructure, a tailored process and collaboration model, and a strategy to drive internal alignment quickly, and iteratively. With long regulatory time horizons, a central challenge is ensuring products are relevant, timely and competitive by the time they hit the market. IA Collaborative helps organizations conduct the right sequence of behavioral design research and usability testing to ensure that products are effective in changing behavior – before they head into clinical trials.

4 / De-Risking Investment<br/>

IA Collaborative teams function as an extension of our client’s team, leading product strategy, research and design to move from early prototypes to MVPs to impelmentation. Through this process, we gather data that proves how our digital therapies positively impact adherence, justifying the investment as a mutually beneficial one for our Pharma client partners, providers, payers, and patients. We help “de-risk” the clinical trial process by ensuring concepts have been explored, iterated, co-created with end users and validated through rapid user testing before entering the regulatory process. By defining the precise user experience that will generate the biggest impact, we help you determine whether you should build from within, buy, or partner to create your digital therapy product.